What does this research mean for the field?

Periodic cardiovascular screening was associated with a reduction in sudden cardiac death incidence among young athletes. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to assess the effectiveness of periodic cardiovascular screening in preventing sudden cardiac death among young athletes.

January 9, 2026Quality in SportOpen Access

Periodic cardiovascular screening was associated with a reduction in sudden cardiac death incidence among young athletes.

Q: What is the clinical evidence from this study?

Study design: Other. Population: Sudden Cardiac Death in Young Athletes (n=22324). Intervention: Periodic Cardiovascular Screening (Pre-participation screening, PPS) vs. Control group (no screening). Primary outcome: Incidence of sudden cardiac death (SCD) (null, 95% CI null, p=null).

View Full Paper

Ask AI

Bookmark

Key result

Periodic cardiovascular screening was associated with a reduction in sudden cardiac death incidence among young athletes.

Authors

AGAdrian Gólcz MSMikołaj Szaryński ASAdam Sikorski

Discussion

Member takes

Overview

This review evaluates cardiovascular screening's impact on preventing sudden cardiac death in young athletes, suggesting adaptation to local systems.

Key Points

The aim is to assess the effectiveness of periodic cardiovascular screening in preventing sudden cardiac death among young athletes.
Review current evidence on pre-participation screening protocols
Analyze incidence rates of sudden cardiac death among athletes under 35
Examine the effectiveness of ECG-based screening in identifying cardiac disorders
Discuss the cost-effectiveness and logistical challenges of screening programs
Evaluate the role of emerging technologies in future screening strategies.
Current incidence of sudden cardiac death is estimated at 1–3 cases per 100,000 athletes
Periodic screenings may reduce SCD incidence by identifying life-threatening conditions
High false-positive rates and economic costs pose challenges to widespread implementation
The effectiveness of screening varies depending on local healthcare capabilities and disease prevalence
Emerging technologies may enhance the precision of SCD prevention efforts.

PICO

Population

Sudden Cardiac Death in Young Athletes (n=22,324)

Intervention / Comparator

Periodic Cardiovascular Screening (Pre-participation screening, PPS) vs Control group (no screening)

Primary Outcome

Incidence of sudden cardiac death (SCD) — null (null), p=null

Main Result

Effect estimate: null (95% CI null)

Absolute Event Rate: 0.4% vs 3.6%

p-value: p=null

Limitations

Insufficient randomized controlled evidence confirming that PPS significantly reduces SCD mortality.
High false-positive rates leading to unnecessary interventions.

Cite This Study

Gólcz et al. (2025) studied Sudden Cardiac Death in Young Athletes (n=22,324). Periodic Cardiovascular Screening (Pre-participation screening, PPS) vs. Control group (no screening) was evaluated on Incidence of sudden cardiac death (SCD) (null, 95% CI null, p=null). Periodic cardiovascular screening was associated with a reduction in sudden cardiac death incidence among young athletes.

synapsesocial.com/papers/696128f244c2cd6c68456c7a https://doi.org/10.12775/qs.2025.48.67154

View Full Paper

Ask AI

Bookmark

January 9, 2026Quality in SportOpen Access

Periodic cardiovascular screening was associated with a reduction in sudden cardiac death incidence among young athletes.

View Full Paper

Ask AI

Bookmark

Key result

Periodic cardiovascular screening was associated with a reduction in sudden cardiac death incidence among young athletes.

Authors

AGAdrian Gólcz MSMikołaj Szaryński ASAdam Sikorski

Discussion

Member takes

Overview

This review evaluates cardiovascular screening's impact on preventing sudden cardiac death in young athletes, suggesting adaptation to local systems.

Key Points

The aim is to assess the effectiveness of periodic cardiovascular screening in preventing sudden cardiac death among young athletes.
Review current evidence on pre-participation screening protocols
Analyze incidence rates of sudden cardiac death among athletes under 35
Examine the effectiveness of ECG-based screening in identifying cardiac disorders
Discuss the cost-effectiveness and logistical challenges of screening programs
Evaluate the role of emerging technologies in future screening strategies.
Current incidence of sudden cardiac death is estimated at 1–3 cases per 100,000 athletes
Periodic screenings may reduce SCD incidence by identifying life-threatening conditions
High false-positive rates and economic costs pose challenges to widespread implementation
The effectiveness of screening varies depending on local healthcare capabilities and disease prevalence
Emerging technologies may enhance the precision of SCD prevention efforts.

PICO

Population

Sudden Cardiac Death in Young Athletes (n=22,324)

Intervention / Comparator

Periodic Cardiovascular Screening (Pre-participation screening, PPS) vs Control group (no screening)

Primary Outcome

Incidence of sudden cardiac death (SCD) — null (null), p=null

Main Result

Effect estimate: null (95% CI null)

Absolute Event Rate: 0.4% vs 3.6%

p-value: p=null

Limitations

Insufficient randomized controlled evidence confirming that PPS significantly reduces SCD mortality.
High false-positive rates leading to unnecessary interventions.

Cite This Study

synapsesocial.com/papers/696128f244c2cd6c68456c7a https://doi.org/10.12775/qs.2025.48.67154

View Full Paper

Ask AI

Bookmark